Liposomal delivery of camptothecins
- 1 June 2000
- journal article
- Published by Elsevier in Pharmaceutical Science & Technology Today
- Vol. 3 (6) , 205-209
- https://doi.org/10.1016/s1461-5347(00)00268-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The development of combination therapy involving camptothecins: a review of preclinical and early clinical studiesCancer Treatment Reviews, 1998
- Lipid-complexed camptothecin: formulation and initial biodistribution and antitumor activity studiesCancer Chemotherapy and Pharmacology, 1996
- Reduced Albumin Binding Promotes the Stability and Activity of Topotecan in Human BloodBiochemistry, 1995
- The Important Role of Albumin in Determining the Relative Human Blood Stabilities of the Camptothecin Anticancer DrugsJournal of Pharmaceutical Sciences, 1995
- Marked Interspecies Variations Concerning the Interactions of Camptothecin with Serum Albumins: A Frequency-Domain Fluorescence Spectroscopic StudyBiochemistry, 1994
- Differential Interactions of Camptothecin Lactone and Carboxylate Forms with Human Blood ComponentsBiochemistry, 1994
- The structural basis of camptothecin interactions with human serum albumin: impact on drug stabilityJournal of Medicinal Chemistry, 1994
- Preferential Binding of the Carboxylate Form of Camptothecin by Human Serum AlbuminAnalytical Biochemistry, 1993
- Lipid bilayer partitioning and stability of camptothecin drugsBiochemistry, 1993
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966